RituximabRelapse of non-Hodgkin's lymphoma with loss of CD20 immunoreactivity: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2003年 / 980卷 / 1期
关键词：
Lymphoma; Complete Remission; Mitoxantrone; Follicular Lymphoma; Fludarabine;
D O I：
10.2165/00128415-200309800-00059
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：20 / 20
相关论文
共 50 条
  • [1] RituximabRelapse of non-Hodgkin's lymphoma: case report
    [J]. Reactions Weekly, 2006, 1121 (1) : 21 - 21
  • [2] Identification of CD20 C-Terminal Deletion Mutations Associated with Loss of CD20 Expression in Non-Hodgkin's Lymphoma
    Terui, Yasuhito
    Mishima, Yuji
    Sugimura, Natsuhiko
    Kojima, Kiyotsugu
    Sakurai, Takuma
    Mishima, Yuko
    Kuniyoshi, Ryoko
    Taniyama, Akiko
    Yokoyama, Masahiro
    Sakajiri, Sakura
    Takeuchi, Kengo
    Watanabe, Chie
    Takahashi, Shunji
    Ito, Yoshinori
    Hatake, Kiyohiko
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (07) : 2523 - 2530
  • [3] Circulating CD20 and CD52 in patients with non-Hodgkin's lymphoma or Hodgkin's disease
    Giles, FJ
    Vose, JM
    Do, KA
    Johnson, MM
    Manshouri, T
    Bociek, G
    Bierman, PJ
    O'Brien, SM
    Keating, MJ
    Kantarjian, HM
    Armitage, JO
    Albitar, M
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2003, 123 (05) : 850 - 857
  • [4] Immuno-PET Imaging for CD20 Expression in Non-Hodgkin's Lymphoma
    Bozkir, E. T. Sarcan
    Paisey, S.
    Ruthardt, M.
    Ozer, A. Y.
    Marshall, C.
    Hartman, N.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S435 - S435
  • [5] Identification of CD20 mutation associated with modification of CD20 expression and poor prognosis after rituximab in non-Hodgkin's lymphoma
    Terui, Y.
    Mishima, Y.
    Yokoyama, M.
    Kodaira, M.
    Takeuchi, K.
    Hatake, K.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 115 - 115
  • [6] Non-Hodgkin's Lymphoma: A Case Report
    Patel, Aditya
    Gujar, Samrudhi
    Pohekar, Savita
    Ankar, Ruchira
    Raut, Arati
    Sakharkar, Sheetal
    Tembhare, Vaishali
    Wagh, Pranali
    [J]. JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (53B) : 264 - 267
  • [7] Novel CD20 Mutations As a Mechanism of Resistance to CD20-CD3 Targeted Therapies in Non-Hodgkin's Lymphoma
    Maximov, Victor
    Bolen, Christopher R.
    Polson, Andrew G.
    Penuel, Elicia
    Lasater, Elisabeth A.
    [J]. BLOOD, 2023, 142
  • [8] MT-3724, an engineered toxin body targeting CD20 for non-Hodgkin's lymphoma
    Robinson, Garrett L.
    Rajagopalan, Sangeetha
    Brieschke, Brigitte
    Erdman, Jennifer
    Neill, Jane
    Flores-Lefranc, Rodney E.
    Foree, Julia
    Null, William
    Liu, Jensing
    Higgins, Jack P.
    Willert, Erin K.
    [J]. CANCER RESEARCH, 2016, 76
  • [9] Radiobiology of radioimmunotherapy: Targeting CD20 B-cell antigen in non-Hodgkin's lymphoma
    Hernandez, MC
    Knox, SJ
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (05): : 1274 - 1287
  • [10] CD20 expression in normal canine B cells and in canine non-Hodgkin lymphoma
    Jubala, CM
    Wojcieszyn, JW
    Valli, VEO
    Getzy, DM
    Fosmire, SP
    Coffey, D
    Bellgrau, D
    Modiano, JF
    [J]. VETERINARY PATHOLOGY, 2005, 42 (04) : 468 - 476
12345